the comparative prophylactic effectiveness of oral treatment with ribavirin ( 1-beta-d-ribofuranosyl-1,2,4 , triazole-3-carboxamide ; virazole ) and amantadine hydrochloride against artificially induced infection with influenza a virus was evaluated in 29 seronegative men who received ribavirin capsules ( 200 mg ) three times daily , placebo capsules three times daily , or amantadine capsules ( 100 mg ) twice daily .
C0936072
amantadine
C0002403
amantadine